Central Nebraska Medical Clinic

Clinical Trials At Central Nebraska Medical Clinic

Wednesday, February 18, 2009

The following studies are currently available for enrollment at Central Nebraska Medical Clinic:

Diabetes

1. GLP153 – A randomized, double blind, placebo controlled study to evaluate a new once-weekly injectable diabetes medicine. Open to Type 2 diabetics who are not controlled on Glucophage alone.
2. GLP154 – A long term safety study for the injectable diabetes medicine mentioned above. Open to Type 2 diabetics who are not controlled on Glucophage or Glucophage and another medicine.
3. GLP155 – A randomized, double blind, parallel-group study to evaluate safety of twice-weekly injections of the new diabetes medicine mentioned above, plus oral medicine. Open to Type 2 diabetics who not controlled on one or two medicines.
4. GLP156 – A randomized, double blind, placebo controlled, parallel-group study to compare the safety of twice-weekly injection of the new diabetes medicine mentioned above as compared to placebo. Open to Type 2 diabetics who are not controlled on diet and exercise alone.
5. GLP157 – A randomized, double blind, placebo controlled, parallel-group study to evaluate safety of once weekly injection of the new diabetes medicine mentioned above in combination with 3 other oral medicines. Open to Type 2 diabetics who are not controlled on two medicines alone.

Osteoarthritis

1. A randomized, open label study of Celebrex compared with ibuprofen to evaluate the potential of ulcer production. Open to patients with osteoarthritis.

Soft Tissue Injury

1. A randomized, double blind, placebo controlled study to assess effectiveness of topical Ketoprofen cream for tendonitis, acute sprains, and bursitis. Open to patients with the aforementioned injuries.

Constipation

1. An observational, longitudinal, multi-centre study to compile data on treatment of patients with chronic constipation. Open to any patient with chronic constipation.

You can talk with your doctor or Terri Leibert about enrolling in these studies. Call the clinic or send us a message if you are interested.